These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8854227)

  • 1. Application of response surface methodology and factorial designs to clinical trials for drug combination development.
    Stewart WH
    J Biopharm Stat; 1996 Jul; 6(3):219-30. PubMed ID: 8854227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response curves in antihypertensive combination therapy: results of a controlled clinical trial.
    Letzel H; Bluemner E
    J Hypertens Suppl; 1990 Sep; 8(4):S83-6. PubMed ID: 2258790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, controlled trial comparing diltiazem, hydrochlorothiazide, and their combination in the therapy of essential hypertension.
    Pool PE; Applegate WB; Woehler T; Sandall P; Cady WJ
    Pharmacotherapy; 1993; 13(5):487-93. PubMed ID: 8247917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
    Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach to the assessment of therapeutic drug interactions with fixed combination drug products.
    Rockhold FW; Goldberg MR
    J Biopharm Stat; 1996 Jul; 6(3):231-40. PubMed ID: 8854228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan/hydrochlorothiazide: a new fixed dose combination.
    Maillard M; Burnier M
    Expert Rev Cardiovasc Ther; 2005 May; 3(3):375-86. PubMed ID: 15889965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of time trends, individual subject responses and background variation in crossover factorial studies with antihypertensive drugs.
    Chalmers J; Wing L; Taylor S
    J Hypertens Suppl; 1990 Sep; 8(4):S27-35. PubMed ID: 2258780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
    Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
    J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of a diuretic added to diltiazem.
    MacGregor GA; Cappuccio FP
    J Hum Hypertens; 1997 Apr; 11(4):249-50. PubMed ID: 9185031
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valsartan/hydrochlorothiazide: pharmacology and clinical efficacy.
    Kondrack R; Mohiuddin S
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1125-34. PubMed ID: 19689218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical development of therapy with two antihypertensive agents in fixed combination].
    Ménard I
    J Hum Hypertens; 1995 Aug; 9 Suppl 4():S11-7. PubMed ID: 7674267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perindopril + indapamide: new preparation. Simple trick.
    Prescrire Int; 1999 Dec; 8(44):172-5. PubMed ID: 11503814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of a multiple-dose, combination-drug clinical trial using response surface methodology.
    Phillips JA; Cairns V; Koch GG
    J Biopharm Stat; 1992; 2(1):49-67. PubMed ID: 1300205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closure procedures for monotone bi-factorial dose-response designs.
    Hellmich M; Lehmacher W
    Biometrics; 2005 Mar; 61(1):269-76. PubMed ID: 15737103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.